EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory Polymorphisms (IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors

César Fernández-de-Las-Peñas iD, Gema Díaz-Gil iD, Antonio Gil-Crujera iD, Stella M Gómez-Sánchez iD, Silvia Ambite-Quesada iD, Juan Torres-Macho iD, Pablo Ryan-Murua iD, Ana I Franco-Moreno iD, Oscar J Pellicer-Valero iD, Lars Arendt-Nielsen iD, Rocco Giordano iD

Viruses · 2024

DOI: 10.3390/v16020275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von César Fernández-de-Las-Peñas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain. Hauptthemen laut MEDLINE: COVID-19, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Comunidad de Madrid, Novo Nordisk Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to identify the association between four selected inflammatory polymorphisms with the development of long-term post-COVID symptoms in subjects who had been hospitalized due to SARS-CoV-2 infection during the first wave of the pandemic. These polymorphisms were selected as they are associated with severe COVID-19 disease and cytokine storm, so they could be important to prognoses post-COVID. A total of 408 (48.5% female, age: 58.5 ± 14.0 years) previously hospitalized COVID-19 survivors participated. The three potential genotypes of the following four single-nucleotide polymorphisms, IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252, were obtained from non-stimulated saliva samples of the participants. The participants were asked to self-report the presence of any post-COVID symptoms (defined as symptoms that had started no later than one month after SARS-CoV-2 acute infection) and whether the symptoms persisted at the time of the study. At the time of the study (mean: 15.6, SD: 5.6 months after discharge), 89.4% of patients reported at least one post-COVID symptom (mean number of symptoms: 3.0; SD: 1.7). Fatigue (69.3%), pain (40.9%), and memory loss (27.2%) were the most prevalent post-COVID symptoms in the total sample. Overall, no differences in the post-COVID symptoms depending on the IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252 genotypes were seen. The four SNPs assessed, albeit having been previously associated with inflammation and COVID-19 severity, did not cause a predisposition to the development of post-COVID symptoms in the previously hospitalized COVID-19 survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Tumor Necrosis Factor-alphaAdultAgedFemaleHumansMaleMiddle AgedInterleukin-10Interleukin-6Membrane ProteinsPolymorphism, Single NucleotideRNA-Binding ProteinsSARS-CoV-2

Stichwörter der Autor:innen

IFITM3IL-10TNF-αgenotypespost-COVIDsingle-nucleotide polymorphism, IL-6

Substanzen

IFITM3 protein, humanInterleukin-10Interleukin-6Membrane ProteinsRNA-Binding ProteinsTumor Necrosis Factor-alphaIL10 protein, humanIL6 protein, human

Autor:innen und Institutionen

  • Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain.
  • Center for Neuroplasticity and Pain (CNAP), Sensory Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.
  • Research group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28933 Madrid, Spain.
  • Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.
  • Department of Medicine, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.
  • Image Processing Laboratory (IPL), Universitat de València, Parc Científic, Paterna, 46100 València, Spain.

ORCID-Profile: César Fernández-de-Las-Peñas, Gema Díaz-Gil, Antonio Gil-Crujera, Stella M Gómez-Sánchez, Silvia Ambite-Quesada, Juan Torres-Macho, Pablo Ryan-Murua, Ana I Franco-Moreno, Oscar J Pellicer-Valero, Lars Arendt-Nielsen, Rocco Giordano

Förderung

  • Comunidad de Madrid
  • Novo Nordisk Foundation

Zitieren

APA

Fernández-de-Las-Peñas, C., Díaz-Gil, G., Gil-Crujera, A., Gómez-Sánchez, S. M., Ambite-Quesada, S., Torres-Macho, J., Ryan-Murua, P., Franco-Moreno, A. I., Pellicer-Valero, O. J., Arendt-Nielsen, L., & Giordano, R. (2024). Inflammatory Polymorphisms (IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors. Viruses. https://doi.org/10.3390/v16020275

Vancouver

Fernández-de-Las-Peñas C, Díaz-Gil G, Gil-Crujera A, Gómez-Sánchez SM, Ambite-Quesada S, Torres-Macho J, et al. Inflammatory Polymorphisms (IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors. Viruses. 2024. doi:10.3390/v16020275

BibTeX
@article{FernndezdeLasPeas2024,
  author = {Fernández-de-Las-Peñas, César and Díaz-Gil, Gema and Gil-Crujera, Antonio and Gómez-Sánchez, Stella M and Ambite-Quesada, Silvia and Torres-Macho, Juan and Ryan-Murua, Pablo and Franco-Moreno, Ana I and Pellicer-Valero, Oscar J and Arendt-Nielsen, Lars and Giordano, Rocco},
  title = {Inflammatory Polymorphisms (IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16020275}
}
Kostenlos starten →